PharmAthene Inc (NYSE MKT LLC:PIP)

Add to Watch List

Set Alert

1.60 Data as of May 24	-0.02 / -1.23% Today’s Change	0.98 Today\|\|\|52-Week Range 2.05	+42.86% Year-to-Date

1.60

Data as of May 24

-0.02 / -1.23%

Today’s Change

0.98

Today|||52-Week Range

2.05

+42.86%

Year-to-Date

SECTOR

Commercial Services

INDUSTRY

Miscellaneous Commercial Services

MARKET CAP

$79.1M

Company Description

PharmAthene, Inc. is biodefense company engaged in the development and commercialization of medical countermeasures against biological and chemical weapons. Its product development programs include: SparVax, a second generation recombinant protective antigen anthrax vaccine; Valortim, a fully human monoclonal antibody for the prevention and treatment of anthrax infection; and Recombinant BChE, countermeasures for nerve agent poisoning by organophosphorous compounds, including nerve agents and pesticides. The company was founded in March 2001 and is headquartered in Annapolis, MD.

Contact Information

PharmAthene, Inc.

1 Park Place

Annapolis Maryland 21401

P:(410) 269-2600

Investor Relations:
(410) 269-2697

www.pharmathene.com

Employees

Shareholders

Individual stakeholders	31.14%
Other institutional	19.34%
Mutual fund holders	1.77%

Top Executives

Eric I. Richman, MBA	President, Chief Executive Officer, COO & Director
Linda L. Chang, MBA, CPA	Chief Financial Officer & Senior Vice President
Arthur Y. Elliott, PhD	Chief Scientific Officer
Jordan P. Karp	Secretary, Senior Vice President & General Counsel
Jeffrey M. Jones	Senior Director-Business Development

To view my watchlist

Not a member yet?

jobs by

Search for jobs

Search All Jobs from Across the Web

About CNNMoney
Content
Magazines
Site Tools
Stay Connected
- My Account
- Mobile Site & Apps
- Facebook
- Twitter
- LinkedIn
- YouTube
- RSS Feeds
- Newsletters
- Tumblr
- Google+

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2013 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones Indexes^SM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones Indexes^SM © 2013 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2013. All rights reserved. Most stock quote data provided by BATS.